Several experimental investigations have been carried out on blood samples and cerebrospinal fluid (CSF) samples in AD patients, and these samples revealed enhanced expressions of proinflammatory markers including IL-2, IL-6, IL-1β, TNF-α, and IL-10 anti-inflammatory markers [48]. This evidence concerns the gene IL1B and Alzheimer disease.